Blue Jet Healthcare Limited — Investor Meet, 22-07-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Blue Jet Healthcare posted strong Q1 FY26 results. Revenue surged to Rs. 354.8 Cr (up 117.8% YoY). EBITDA at Rs. 121.0 Cr (up 173.3% YoY) with 34.1% margin. PAT was Rs. 91.2 Cr (up 141.3% YoY) at 25.7% margin. While QoQ margins softened due to product mix, the company plans capacity expansion, R&D investment, and value chain integration in Contrast Media and Pharma Intermediates & API. Management appears focused on growth and operational efficiency.